All links accessed April 5 2020.

1. Royal College of Physicians & British Pharmacological Society. ‘Personalised prescribing: using pharmacogenomics to improve patient outcomes’. March 24 2022. https://www.rcp.ac.uk/projects/outputs/personalised-prescribing-using-pharmacogenomics-improve-patient-outcomes
2. Royal Pharmaceutical Society in Scotland. ‘Pharmacy 2030: a professional vision’. January 2022. https://www.rpharms.com/pharmacy2030
3. NHS. National Genomic Test Directory. August 2018, last updated February 2022. https://www.england.nhs.uk/publication/national-genomic-test-directories/
4. Department for Business, Energy and Industrial Strategy, Department of Health & Social Care, Office for Life Sciences. Policy paper. ‘Genome UK: the future of healthcare’. September 26 2020. https://www.gov.uk/government/publications/genome-uk-the-future-of-healthcare/genome-uk-the-future-of-healthcare
5. NHS Genomic Medicine Service. https://www.england.nhs.uk/genomics/nhs-genomic-med-service/
6. NHS. Letter. ‘Genomic Medicine Service alliances and role of pharmacy within the new structure. Update for hospital chief pharmacist and CCG lead pharmacists’. July 2020. https://www.england.nhs.uk/wp-content/uploads/2020/07/B0044-GMS-update-for-Chief-Pharmacists-14-July.pdf
7. NHS Health Education England (HEE). Genomics Education Programme. Genomics in Primary Care. https://www.genomicseducation.hee.nhs.uk/genomics-in-healthcare/genomics-in-primary-care/
8. Center for Disease Control and Prevention (CDC). Genomics & Precision Health. ‘Pharmacogenomics: What does it mean for your health?’. Page last reviewed: October 29 2018. https://www.cdc.gov/genomics/disease/pharma.htm
9. DHSC. Genomics England. Genomic Medicine. https://www.genomicsengland.co.uk/
10. National Human Genome Research Institute. The Human Genome Project. https://www.genome.gov/human-genome-project
11. A Tornio and JT Backman. ‘Chapter One - Cytochrome P450 in Pharmacogenetics: An Update’. Advances in Pharmacology. 2018. 83:3-32. https://www.sciencedirect.com/science/article/abs/pii/S1054358918300267
12. National Center for Biotechnology Information, U.S. National Library of Medicine. Gene. https://www.ncbi.nlm.nih.gov/gene
13. SJ Lee. Clinical application of CYP2C19 pharmacogenetics toward more personalized medicine. Front. Genet. February 1 2013. https://www.frontiersin.org/articles/10.3389/fgene.2012.00318/full
14. National Library of Medicine. MedlinePlus. Pharmacogenetic Tests. Page last reviewed July 2021/ https://medlineplus.gov/lab-tests/pharmacogenetic-tests/
15. National Human Genome Research Institute. Pharmacogenomics. Last updated April 2018. https://www.genome.gov/dna-day/15-ways/pharmacogenomics
16. emc. Datapharm. https://www.medicines.org.uk/emc
17. Your Genome. ‘How is pharmacogenomics being used?’. Page last updated July 2021. https://www.yourgenome.org/stories/how-is-pharmacogenomics-being-used
18. LS Kaminsky and ZY Zhang. ‘Human P450 metabolism of warfarin’. Pharmacology & Therapeutics. 1997. 73;1:67-74. https://www.sciencedirect.com/science/article/abs/pii/S0163725896001404
19. EJ Philips et al. ‘Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update’. Clinical Pharmacology & Therapeutics. April 2018. 103;4:574-581. https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.1004
20. CA Brunette et al. ‘A Cost–Consequence Analysis of Preemptive SLCO1B1 Testing for Statin Myopathy Risk Compared to Usual Care’. J. Pers. Med. 2021. 11;11:1123. https://www.mdpi.com/2075-4426/11/11/1123
21. Cystic Fibrosis Foundation. Basics of the CFTR Protein. https://www.cff.org/research-clinical-trials/basics-cftr-protein